Us Congress Senate Bill SB2909

Us Congress 2023-2024 Regular Session

• Introduced: 9/21/23
• Refer: 9/21/23

Caption

DEA Act Deferring Executive Authority Act

Impact

If enacted, SB2909 would necessitate congressional approval for any changes regarding the scheduling of marijuana. This marks a significant shift in how marijuana is regulated at the federal level, moving some responsibility back into the hands of lawmakers rather than leaving it solely to executive agencies. The bill could have implications for both present and future marijuana policies, potentially impacting efforts for legalization and regulation, depending on how Congress chooses to address this matter in the future.

Summary

SB2909, titled the Deferring Executive Authority Act (DEA Act), is a legislative proposal aimed at establishing a congressional review process for rules that involve the rescheduling of marijuana under the Controlled Substances Act. The bill requires that before any rule transferring marijuana between different schedules can take effect, the Attorney General must submit a detailed report to both Houses of Congress. This report must include the text of the new rule, a general statement concerning its implications, and the proposed effective date. Such a measure reflects a broader movement towards questioning the executive power in modifying controlled substances classifications without legislative oversight.

Contention

The proposal has sparked debate particularly between those who support cannabis legalization and those who favor stricter controls. Supporters argue that allowing Congress to review and approve scheduling decisions could lead to more well-rounded and considered regulations that reflect societal changes surrounding marijuana use. Conversely, opponents claim that the necessary congressional process could delay much-needed reforms in marijuana policy and maintain the status quo, which some view as overly punitive and outdated.